About
Technology
Issues
FAQ
Links
Official Page
Cost-Effectiveness of Adding Ribociclib to Endocrine Therapy for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer Among Premenopausal or Perimenopausal Women
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.